Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
199.30    2.60 (1.32%)
Bid:
199.00
Ask:
199.30
Spread: 0.30 (0.151%)
Market Cap: £2.00b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Holding(s) in Company

22 Jul 2014 18:15

RNS Number : 0279N
B&M European Value Retail S.A.
22 July 2014
Β 

APPENDIX A

Β 

Β 

Β 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:B&M European Value Retail S.A.

2. Reason for the notification (please tick the appropriate box or boxes):

[X] an acquisition or disposal of voting rights

[ ] an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

[ ] an event changing the breakdown of voting rights

3. Full name of person(s) subject to the notification obligation:

Bank of America Corporation

4. Full name of shareholder(s) (if different from the person mentioned in point 3.):

Merrill Lynch International

5. Date of the transaction and date on which the threshold is crossed or reached:

17/07/2014

6. Threshold(s) that is/are crossed or reached:

Below 5%

7. Notified details:

Β 

A) Voting rights attached to shares (articles 8 and 9 of the Luxembourg transparency law)

Class/type of shares (if possible using the ISIN CODE)

Situation previous to the Triggering transaction

Resulting situation after the triggering transaction

Β 

Β 

Number of voting rights

Β 

Number of voting rights

Percentage of voting rights

Β 

Β 

Β 

Β 

Β 

Direct

Indirect

Direct

Indirect

Common Stock -LU1072616219

10,661,891

Β 

Below notifiable threshold

Β 

Below notifiable threshold

Β 

TOTAL

(based on aggregate voting rights)

10,661,891

Β 

Below notifiable threshold

Β 

Below notifiable threshold

Β 

Β 

Β 

B) Financial Instruments (article 12 of the Luxembourg transparency law)

Β 

Resulting situation after the triggering transaction

Type of Financial Instrument

Expiration Date

Exercise/Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/converted

Percentage of voting rights that may be obtained if the instrument is exercised/converted

N/A

TOTAL

(in relation to all expiration dates)

Β 

8. Chain of controlled undertakings through which the voting rights and/or the Financial Instruments are effectively held, if applicableΒ :

Please see attached documentation for full chain of control.

http://www.rns-pdf.londonstockexchange.com/rns/0279N_-2014-7-22.pdf

9. In case of proxy voting:

N/A

10. Additional information: Done in London on 21st July 2014

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLSEIFIEFLSEEW
Date   Source Headline
24th Jun 20262:00 pmRNSDirector Share Purchase
24th Jun 20267:00 amRNSAppointment of Chief Financial Officer
22nd Jun 20269:00 amRNSDirector/PDMR Shareholding
18th Jun 202610:00 amRNSBoard Retirement
18th Jun 202610:00 amRNSPublication of Annual Report and Notice of AGM
16th Jun 202612:00 pmRNSDirector/PDMR Shareholding
11th Jun 20261:00 pmRNSTiming of Q1 FY27 Trading Statement
3rd Jun 20267:00 amRNSFY26 Preliminary Results
10th Apr 20269:00 amRNSDirectorate Changes and Leadership Appointments
26th Mar 20264:45 pmRNSMajor Holding(s) in Company - TR1
24th Mar 20264:30 pmRNSMajor Holding(s) in Company - TR1
17th Mar 20265:31 pmRNSMajor Holding(s) in Company - TR1
17th Mar 20265:30 pmRNSMajor Holding(s) in Company - TR1
9th Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20268:00 amRNSAdmission of B&M Jersey Shares
2nd Mar 20268:00 amRNSReadmission - B&M European Value Retail S.A.
27th Feb 20264:48 pmRNSMigration Completion
25th Feb 202611:00 amRNSPublication of a Prospectus - Migration
24th Feb 20261:00 pmRNSDirector/PDMR Shareholding
22nd Jan 20262:00 pmRNSUpdate statement on 2025 AGM voting results
22nd Jan 20267:00 amRNSQ3 FY26 Trading Statement
15th Jan 20269:00 amRNSBlock listing Interim Review
23rd Dec 20252:00 pmRNSTiming of Q3 FY26 Trading Statement
23rd Dec 20252:00 pmRNSTiming of Q3 FY26 Trading Statement
19th Dec 20259:00 amRNSMajor Holding in Company - TR1
19th Dec 20259:00 amRNSMajor Holding in Company - TR1
4th Dec 202510:00 amRNSMajor Holding in Company - TR1
28th Nov 202511:00 amRNSMajor Holding in Company - TR1
26th Nov 20259:30 amRNSMajor Holding in Company TR1
24th Nov 20252:30 pmRNSMajor Holding in Company- TR1
20th Nov 20254:00 pmRNSCEO Purchase of shares
20th Nov 202511:00 amRNSCEO Purchase of Shares
19th Nov 20259:01 amRNSCEO Purchase of Shares
19th Nov 20259:00 amRNSMajor Holding in Company TR1
18th Nov 202511:00 amRNSCEO Purchase of Shares
18th Nov 202510:58 amRNSMajor Holding in Company- TR1
14th Nov 20253:30 pmRNSMajor Holding in Company TR1
13th Nov 20257:00 amRNSFY26 Interim Results
4th Nov 20256:05 pmRNSMajor Holding in Company TR1
4th Nov 20256:00 pmRNSMajor Holding in Company TR1
30th Oct 20259:00 amRNSMajor Holding in Company TR1
28th Oct 20254:00 pmRNSMajor Holding in Company TR1
27th Oct 20251:01 pmRNSMajor Holding in Company TR1
27th Oct 20251:00 pmRNSMajor Holding in Company TR1
20th Oct 20257:00 amRNSUpdate on FY26 Guidance and Directorate Change
13th Oct 20253:30 pmRNSInformation to shareholders: statutory migration
7th Oct 20257:00 amRNSFY26 H1 Trading and Operational Update
22nd Sep 202511:30 amRNSCEO Purchase of Shares
18th Sep 20256:00 pmRNSDirector/PDMR Shareholding
15th Sep 20254:34 pmRNSCEO Purchase of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.